JSM 2011 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.


339	Tue, 8/2/2011, 10:30 AM - 12:20 PM	CC-C222
Statistical Considerations in the Analysis of Progressive Free Survival — Topic Contributed Papers
Biopharmaceutical Section , Section for Statistical Programmers and Analysts , Section on Statistics in Epidemiology
Organizer(s): Jing Xu, Millennium Pharmaceuticals
Chair(s): Satrajit Roychoudhury, Novartis
10:35 AM	Predicting Analysis Time in Event-Driven Clinical Trials with Event-Reporting Lag — Jianming Wang, Novartis Oncology ; Chunlei Ke, Amgen Inc. ; Qi Jiang, Amgen Inc. ; Charlie Zhang, Exelixis ; Steve Snapinn, Amgen Inc.
10:55 AM	The Effect of Periodic Follow-Up: Design and Analysis of Progression-Free Survival Data — Zhigang Zhang, MSKCC
11:15 AM	Some Practical Issues in PFS Analysis from Industry Perspective — Jingyuan Wang, Millennium Pharmaceuticals ; Connie Lee, Millennium Pharmaceuticals ; Jing Xu, Millennium Pharmaceuticals ; Yuanjun Shi, Millennium Pharmaceuticals
11:35 AM	Regulatory Considerations in the Evaluation of Progression-Free Survival — Rajeshwari Sridhara, U.S. Food and Drug Administration
11:55 AM	Issues in the Analysis of Progression-Free Survival from a Cancer Clinical Trial — Dianne M. Finkelstein, Massachusetts General Hospital/Harvard School of Public Health
12:15 PM	Floor Discussion

2011 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.